KPJ Healthcare Earnings Likely to Improve in 2Q

Dow Jones
08/13

0104 GMT - KPJ Healthcare could post sequentially stronger 2Q core net profit, driven by improving patient volume and revenue intensity, alongside margin recovery, RHB IB analyst Eddy Do says in a note. He tips 2Q core net profit at 92 million ringgit, which is 16% stronger on year and 28% higher sequentially. Additional growth could come from newer hospitals moving into profitability as operations mature, he says. KPJ's third center of excellence launch should also support longer-term revenue growth, he adds. RHB maintains a buy rating on KPJ and keeps its target price at 3.77 ringgit. Shares are unchanged at 3.07 ringgit.

 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10